PARD6G-AS1: A Potential Drug Target and Biomarker (G100130522)

Target Name: PARD6G-AS1

NCBI ID: G100130522

PARD6G-AS1

Other Name(s): PARD6G-AS1 variant 1 | PARD6G antisense RNA 1 | PARD6G antisense RNA 1, transcript variant 1

PARD6G-AS1: A Potential Drug Target and Biomarker

Pard6G-AS1, also known as AS1, is a gene located on chromosome 6 and was discovered as a potential drug target and biomarker for various diseases. The protein encoded by this gene has been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The PARD6G-AS1 gene was identified through a variety of techniques, including transcriptomics, RNA sequencing, and gene expression analysis. Studies have shown that the PARD6G-AS1 gene is highly expressed in a variety of tissues and cells, including brain, spinal cord, and peripheral tissues, and has been implicated in the development and progression of several diseases.

One of the key functions of PARD6G-AS1 is its role in the regulation of cellular processes that are critical for disease development, such as cell signaling, apoptosis, and inflammation. Studies have shown that the PARD6G-AS1 gene is involved in the regulation of several signaling pathways that are involved in the development of cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its role in disease development, PARD6G-AS1 has also been shown to be a potential biomarker for several diseases. The protein encoded by this gene has been shown to be expressed in a variety of tissues and cells and has been used as a biomarker for diseases such as cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key advantages of PARD6G-AS1 as a potential drug target is its small size and the ease with which it can be modified and developed into a drug. This makes it an attractive candidate for drug development due to its potential impact on a wide range of diseases.

In conclusion, PARD6G-AS1 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in disease development and to develop effective treatments.

Protein Name: PARD6G Antisense RNA 1

The "PARD6G-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PARD6G-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets